Brief: Adial Pharmaceuticals Announces Database Lock For The Onward Phase 3 Clinical Trial

Azora Therapeutics

27/06/2022 17:48

June 27 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS ANNOUNCES DATABASE LOCK FOR THE
ONWARD™
PHASE 3 CLINICAL TRIAL

Source text for Eikon:  ID:nGNXJvQw0 
Further company coverage:  ADIL.O